Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether investigational study drug, AG-013736, and
gemcitabine are effective in the first-line treatment of advanced pancreatic cancer.